• Skip to primary navigation
  • Skip to main content
  • Skip to footer

Target ALS

A New York based ALS research organization that's leading the fight for a cure.

  • DONATE
  • About Us
    • Our Mission
    • Our Model
    • Our Impact
    • Our Founder
    • Our Team
    • Our Partners
  • For Scientists
    • Research Cores
      • Target ALS Data Engine
      • Longitudinal Biofluids Core
      • Human Postmortem Tissue Core
      • Stem Cell Core
      • Reagents Core
      • Animal Models Core
    • Funding Opportunities
    • Funded Projects
    • Annual Meeting
    • Science on Target Blog
    • FAQs for Researchers
  • Understanding ALS
    • About ALS
    • Understanding the Science
      • Glossary
      • FAQ
      • ALS 101
    • Voices of ALS
    • Video Library
  • Take Action
    • Support Geoff Greulich
    • The ALS Global Research Initiative (AGRI)
      • Global Natural History Study
      • Community Based Pop-Up Clinics
    • Ways to Give
    • Email Sign Up
    • Contact Us
    • Donate Now
  • News
    • Announcements
    • In the News
    • Newsletters & Reports

Science on Target Blog

Target ALS Thought Leadership

Now Live on the Target ALS Data Engine: Landmark Multi-Omics Dataset to Accelerate ALS and FTD Research

Now Live on the Target ALS Data Engine: Landmark Multi-Omics Dataset to Accelerate ALS and FTD Research

The C9orf72 Puzzle: Cracking ALS’s Most Common Genetic Code

The C9orf72 Puzzle: Cracking ALS’s Most Common Genetic Code

Science on Target July 2025 Newsletter

Science on Target July 2025 Newsletter

Everyone Lives: Remarks from Dan Doctoroff at the Target ALS 2025 Annual Meeting

Everyone Lives: Remarks from Dan Doctoroff at the Target ALS 2025 Annual Meeting

From Barriers to Breakthroughs: Our 2025 Annual Meeting Report Is Now Live

From Barriers to Breakthroughs: Our 2025 Annual Meeting Report Is Now Live

Breaking Down Barriers in ALS Research: A Global Call to Action

Breaking Down Barriers in ALS Research: A Global Call to Action

The Innovation Ecosystem

Unlocking Hidden Signals: The Next Frontier in ALS Biomarkers

Unlocking Hidden Signals: The Next Frontier in ALS Biomarkers

Splice Correction of UNC13A: A New Frontier in ALS Treatment

Splice Correction of UNC13A: A New Frontier in ALS Treatment

Unlocking RNA Granules: A Promising Therapeutic Pathway in ALS

Unlocking RNA Granules: A Promising Therapeutic Pathway in ALS

T Cells and ALS: Clues from the Immune System

T Cells and ALS: Clues from the Immune System

Beyond “Junk” DNA: Targeting Transposable Elements in ALS

Beyond “Junk” DNA: Targeting Transposable Elements in ALS

Autophagy and Metabolism: Two Sides of ALS Cellular Breakdown

Autophagy and Metabolism: Two Sides of ALS Cellular Breakdown

Footer

Target ALS
  • Donate
  • Contact
  • Financial Reports
  • Call For Proposals
  • Annual Meeting
  • Privacy Policy
  • Credits

Follow Us

We are a 501(c)(3) public charity (EIN: 81-0756743), eligible to receive tax-deductible contributions that directly support our mission to break down barriers to ALS research to find effective treatments.

The Target ALS (TALS) website is intended for informational purposes only. Opinions expressed may not be that of TALS or its employees. For more information about our digital policies, click here.

© 2023 Target ALS Foundation, Inc.
Target ALS Foundation
244 Madison Avenue #1025
New York, NY 10016
(332) 333-4140
Steck Insights WordPress Consulting